The positions in the table below reflect the Merck Sharp and Dohme B.V. (MSD BV Haarlem)'s position overall, domestically, within their sector, and in various subject areas based on their Share. Each ...
Merck Sharp & Dohme LLC has identified NLRP3 inflammasome inhibitors reported to be useful for the treatment of atherosclerosis, nonalcoholic or metabolic dysfunction-associated steatohepatitis ...
The outbreak of the COVID-19 pandemic demonstrated the need to rapidly develop, produce and distribute large quantities of ...
Dr. Reddy’s (RDY) Laboratories and Senores Pharmaceuticals announced the launch of Ivermectin Tablets USP, 3 mg, which is bioequivalent and therapeutically equivalent to STROMECTOL Tablets of Merck ...
HYDERABAD, India--(BUSINESS WIRE)-- Dr. Reddy's Laboratories, Inc. and Senores Pharmaceuticals, Inc. today announced the launch of Ivermectin Tablets USP, 3 mg, which is bioequivalent and ...
Merck Sharp & Dohme LLC has divulged NLRP3 inflammasome inhibitors reported to be useful for the treatment of atherosclerosis, nonalcoholic or metabolic dysfunction-associated steatohepatitis ...
The U.S. Supreme Court on Monday denied a petition for a writ of certiorari filed by the drug company Merck Sharp & Dohme Corp., bringing to a close a decade-long legal battle that had stalled ...
Article ‘Count’ and ‘Share’ for Merck Sharp and Dohme B.V. (MSD BV Haarlem) based on listed parameters only. The articles listed below published by authors from Merck Sharp and Dohme B.V. (MSD BV ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback